BenevolentAI SA
AEX:BAI

Watchlist Manager
BenevolentAI SA Logo
BenevolentAI SA
AEX:BAI
Watchlist
Price: 0.081 EUR Market Closed
Market Cap: €11.6m

Operating Margin

-1 137%
Current
Declining
by 152.5%
vs 3-y average of -984.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 137%
=
Operating Income
£-63.6m
/
Revenue
£4.9m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 137%
=
Operating Income
€-63.6m
/
Revenue
£4.9m

Peer Comparison

Country Company Market Cap Operating
Margin
UK
BenevolentAI SA
AEX:BAI
11.6m EUR
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

Lower than 99% of companies in United Kingdom
Percentile
1st
Based on 3 579 companies
1st percentile
-1 137%
Low
-195 650% — 0%
Typical Range
0% — 0.2%
High
0.2% — 4 630.7%
Distribution Statistics
United Kingdom
Min -195 650%
30th Percentile 0%
Median 0.1%
70th Percentile 0.2%
Max 4 630.7%

BenevolentAI SA
Glance View

Market Cap
11.6m EUR
Industry
Pharmaceuticals

BenevolentAI SA is a holding company that engages in the research and development and sale of AI-enabled drugs. The firm through the combined capabilities of its AI platform, scientific ability and wet-lab facilities deliver new drug candidates with a higher probability of clinical success than those developed using traditional methods. The company has an array of scientifically validated discoveries. The Company, through its BenevolentAI Platform, offers in-house pipeline of over 20 disease programs, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies, such as AstraZeneca, as well as other research and charitable institutions.

BAI Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1 137%
=
Operating Income
£-63.6m
/
Revenue
£4.9m
What is BenevolentAI SA's current Operating Margin?

The current Operating Margin for BenevolentAI SA is -1 137%, which is below its 3-year median of -984.5%.

How has Operating Margin changed over time?

Over the last 7 months, BenevolentAI SA’s Operating Margin has decreased from -859.9% to -1 137%. During this period, it reached a low of -1 109.1% on Jul 30, 2024 and a high of -859.9% on Dec 1, 2023.

Back to Top